Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis

NCT01558531 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2015-02-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed versus conventional balloon angioplasty in superficial femoral artery and popliteal artery re-stenosis.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

DEB

paclitaxel-eluting balloon angioplasty

DEVICE

POBA

conventional balloon angioplasty

Sponsors & Collaborators

  • Leonardo Bolognese, MD

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01558531 on ClinicalTrials.gov